2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1952336026 MD
Verify on CMS →

Robert Castellucci, MD

Endocrinology, Diabetes & Metabolism Physician in Richmond, Virginia.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
10K
Medicare Part D claims · 922 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
49%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
18.4/100
▼ 65 pts below national avg 83.1 · Penalty band
Industry payments
$705.72
45 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Robert Castellucci, MD reported a CMS MIPS final score of 18.4/100 - below the 83.1 national average - and filed 9,564 Medicare Part D claims in 2023.

18.4/100
MIPS score · -65 vs avg
10K
Part D claims, 2023
49%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Robert Castellucci, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

18 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). This entry sits in this band. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Robert Castellucci, MD sits

This provider among endocrinology, diabetes & metabolism physician peers

Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Robert Castellucci, MD writes more Part D claims than 96% of them and scores higher on MIPS quality than 2% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 68Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 43Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 98Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 30Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 98Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 93Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 65Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 57Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 62Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 73Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 97Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 67Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 45Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 52Robert Castellucci, MD-Part D claim volume, percentile in specialty: 96 · MIPS quality, percentile: 2
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Robert Castellucci, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Robert Castellucci, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Robert Castellucci, MD?

Below national average

NPI registry status

Active

Issued 07/11/2006

NPI 1952336026

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

9,564 262% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

18.4/100 64.7 pts vs avg

Penalty band band

vs 83.1 national avg

Specialty distribution in Virginia

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Virginia providers

Virginia providers
Behavior Technician - 5.2%Behavior Technician5.2%Clinical Social Worker - 5.1%Clinical Social Worker5.1%Student in an Organized Health Care Education/Training Program - 4.7%Student in an Organized Health Care Education/Training Program4.7%Physical Therapist - 4.6%Physical Therapist4.6%Pharmacist - 4.5%Pharmacist4.5%Professional Counselor - 4%Professional Counselor4%Endocrinology, Diabetes & Metabolism Physician - 0.1%Endocrinology, Diabetes & Metabolism Physician0.1%
Largest specialties in Virginia (% of in-state providers)

Medicare quality performance, MIPS

Robert Castellucci, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
18.4/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 18.4/100 vs national avg 83.1

0%100%National avg83%18.4%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 18.4/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Robert Castellucci, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 5875 BREMO ROAD, Richmond, VA, 23226, with a listed phone of (804) 282-9899. NPI 1952336026 was issued on 07/11/2006.

Medicare Part D records for calendar year 2023 show 9,564 prescription claims written by this provider, covering 922 Medicare beneficiaries and totaling roughly $4.1 million in drug spend, split 43% brand-name and 49% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 18.4/100 for the 2023 performance year (Quality 0, Cost 61.2), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5875 BREMO ROAD
Richmond, VA 23226

Provider Details

NPI 1952336026
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 07/11/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

18.365
Final Score
Avg: 83.1
0
Quality
61.2165
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where Robert Castellucci, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Robert P Castellucci MD
Richmond, VA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Robert Castellucci, MD. Source: openpaymentsdata.cms.gov.

Total received

$706

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

Robert Castellucci, MD - brand share 43.0%
Endocrinology, Diabetes & Metabolism Physician average

43% brand-name claims vs 49% generic, on 9,564 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

9,564
Total Claims
$4.1M
Total Drug Cost
922
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
22,128
Total Day Supply
657,551
Brand vs Generic
43% brand / 49% generic
Brand Drug Cost
$3.9M
Generic Drug Cost
$126K
Antibiotic Claims
19

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.52
Gender Split
59% female / 41% male
Age Distribution
<65: 99, 65-74: 418, 75-84: 329, 85+: 76

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Robert Castellucci, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
811
Rosuvastatin Calcium
512
Metformin Hcl Er
Metformin Hcl
495
Synthroid
Levothyroxine Sodium
383
Glipizide Er
Glipizide
337
Atorvastatin Calcium
329
Ozempic
Semaglutide
295
Ezetimibe
175
Humalog Mix 75-25 Kwikpen
Insulin Lispro Protamin/Lispro
169
Metformin Hcl
164

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Robert Castellucci, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

Robert Castellucci, MD's 9,564 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Virginia

Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as Castellucci.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Virginia medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Robert Castellucci, MD's specialty?
Robert Castellucci, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Richmond, Virginia. Credentials: MD.
How much does Robert Castellucci, MD prescribe under Medicare Part D?
In 2023, Robert Castellucci, MD wrote 9,564 Medicare Part D claims totaling $4.1M in drug costs for 922 beneficiaries.
What is Robert Castellucci, MD's Medicare quality score?
Robert Castellucci, MD has a CMS MIPS Final Score of 18.4/100 (Quality: 0, Cost: 61.2). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Robert Castellucci, MD located?
Robert Castellucci, MD is located at 5875 BREMO ROAD, Richmond, VA, 23226. Phone: (804) 282-9899.
What is Robert Castellucci, MD's NPI number?
Robert Castellucci, MD's National Provider Identifier (NPI) is 1952336026, issued on 07/11/2006.
Does Robert Castellucci, MD prescribe more brand-name or generic drugs?
Robert Castellucci, MD's prescribing is 43% brand-name and 49% generic drugs by claim count, with $3.9M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Robert Castellucci, MD prescribe most often?
Based on 2023 Medicare Part D data, Robert Castellucci, MD's most frequently prescribed drugs include Levothyroxine Sodium, Rosuvastatin Calcium, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Castellucci, MD accept Medicare?
Robert Castellucci, MD appears in CMS Medicare data with 9,564 Part D claims and 922 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Castellucci, MD's credentials?
Robert Castellucci, MD's NPI is 1952336026 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.